Profiling Non-Small Cell Lung Cancer: From Tumor to Blood.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26671996.
- Also identified by DOI 10.1158/1078-0432.CCR-15-2514 and PMC identifier 4852855.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Circulating cell-free tumor DNA has shown great promise for noninvasive genomic profiling to guide the administration of targeted therapies in non-small cell lung cancer. With advancements in molecular technology, it is now possible to interrogate multiple clinically actionable genetic drivers in the blood with a single assay.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms